Maxim downgraded Quince Therapeutics (QNCX) to Hold from Buy.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QNCX:
- Spotify upgraded, Pinterest downgraded: Wall Street’s top analyst calls
- Vanguard VTI Daily Snapshot — Jan. 30
- Quince Therapeutics downgraded to Hold from Buy at D. Boral Capital
- Citizens downgrades Quince Therapeutics on study failure
- Quince Therapeutics downgraded to Market Perform from Outperform at Citizens